Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06411990 · ClinicalTrials.gov registry record · NA
Laser In Situ Fenestration Study
A NA study of Aortic Aneurysm and Endovascular Aneurysm Repair, sponsored by Jonathan Bath.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06411990: Recruiting NA study of Aortic Aneurysm and Endovascular Aneurysm Repair, sponsored by Jonathan Bath.
NCT06411990 is a NA study of Aortic Aneurysm and Endovascular Aneurysm Repair that is actively recruiting participants, run by Jonathan Bath. The registered enrollment target is 15 participants, below the 639-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06411990, a NA study of Aortic Aneurysm and Endovascular Aneurysm Repair, is actively recruiting participants, sponsored by Jonathan Bath.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn about a new device, named the LIFE device, to treat people with aneurysms (swellings) in the aorta (large, main blood vessel that delivers blood from the heart to the body). The main questions this trial aims to answer are: * If the LIFE device works to treat aortic aneurysms * What medical problems participants have when the LIFE device is used Participants will undergo treatment with the LIFE device and thereafter at 30 days, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years have their pulses checked, bloodwork to check kidney function (BUN and serum creatinine), and a CT scan of the aneurysm area.
Primary Outcome
Number of subjects with freedom from all cause mortality and freedom from major adverse events. Major adverse events include myocardial infarction, chronic renal insufficiency / chronic renal failure requiring, dialysis, bowel ischemia, stroke, paraplegia or paraparesis, and prolonged ventilatory support.
Conditions Studied
Interventions
- DEVICE Fenestrated Endovascular Aneurysm Repair using the LIFE Device System
Study Locations (1)
Missouri
- University of Missouri - Columbia - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-10-15 |
| Est. Completion | 2031-06 |
| Phase | NA |
What NCT06411990 shows while recruiting
NCT06411990 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 639-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Fenestrated Endovascular Aneurysm Repair using the LIFE Device System is the first listed.
NCT06411990 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT06411990 about?
NCT06411990 is a clinical study titled "Laser In Situ Fenestration Study". The goal of this clinical trial is to learn about a new device, named the LIFE device, to treat people with aneurysms (swellings) in the aorta (large, main blood vessel that delivers blood from the heart to the body). The main questions this trial aims to answer are: * If the LIFE device works to t...
What is the current status of trial NCT06411990?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-10-15. Estimated completion is 2031-06.
What conditions does trial NCT06411990 study?
This clinical trial studies the following conditions: Aortic Aneurysm, Endovascular Aneurysm Repair.
What interventions are being tested in trial NCT06411990?
The interventions under investigation include: Fenestrated Endovascular Aneurysm Repair using the LIFE Device System (DEVICE).
Who is sponsoring clinical trial NCT06411990?
This trial is sponsored by Jonathan Bath, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06411990 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06411990's enrollment target sits among peer trials
15 12th of 14 higher than 2 of 14 other Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Physiology in Patients With Aortic Aneurysm and Its Correlation With Mechanical Properties of Aortic Tissue
RECRUITING · NA
-
Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms
RECRUITING · NA
-
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
RECRUITING · NA
-
Prehabilitation for Aortic Aneurysm Surgery: Proof-of-concept Trial
RECRUITING · NA
-
Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
RECRUITING · NA
-
Radiation Free Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI